Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $13.76 USD
Change Today +0.14 / 1.03%
Volume 75.2K
As of 8:04 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barry D. Quart Pharm.D.

AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 7 different industries.

See Board Relationships


Dr. Barry D. Quart, Pharm.D., has been the Chief Executive Officer at Heron Therapeutics, Inc. since May 2, 2013. Dr. Quart serves as the Scientific Advisor of Napo Pharmaceuticals, Inc. He served as the Chief Executive Officer and President of Ardea Biosciences, Inc. since December 21, 2006, which was acquired by AstraZeneca PLC in June 2012. He served as General Manager for Americas Region, Kodak's Business Solutions and Services of Eastman Kodak Co. He served as the ...

Read Full Background

Corporate Headquarters*

343 State Street
Rochester, New York 14650

United States

Phone: 585-724-4000
Fax: --

Board Members Memberships*

Chief Executive Officer and Director


University of California-San Francisco

Other Affiliations*

Annual Compensation*

Total Annual Compensation$540,750

Stock Options*

All Other Compensation$7,800
Exercisable Options141,067
Exercisable Options Value$240,997
Unexercisable Options1,307,690
Unexercisable Options Value$2,995,369
Total Value of Options$3,236,365
Total Number of Options1,448,757

Total Compensation*

Total Annual Cash Compensation$801,351
Total Short Term Compensation$540,750
Other Long Term Compensation$7,800
Total Calculated Compensation$3,884,259
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KODK:US $13.76 USD +0.14


Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Olivier Brandicourt Chief Executive Officer and Director
Dov Tamarkin Ph.D.Co-Founder, Chief Executive Officer and Director
Foamix Pharmaceuticals Ltd.
Leon O. Moulder Jr., M.B.A.Co-Founder, Chief Executive Officer and Director
Tesaro, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EASTMAN KODAK CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at